Market Overview: The global Smallpox Treatment Market is estimated to be valued at US$ 67.49 million in 2023, with a CAGR of 1.8% from 2023 to 2030, according to a new report by Coherent Market Insights. The market primarily consists of companies such as SIGA Technologies Inc., Bavarian Nordic A/S, Takeda Pharmaceutical Company Limited, Johnson & Johnson, Emergent BioSolutions Inc.,...
Smallpox is a serious and sometimes fatal contagious disease. It is caused by either of two virus variants, Variola major and Variola minor. The signs and symptoms usually appear 12–14 days after infection and then the rash and sores usually scab over and fall off within 4 weeks. However, in rare cases it can cause serious complications or even death. Smallpox treatment options include...
The smallpox treatment market deals with products and therapies related to treatment of smallpox disease. Some key products include vaccines, antiviral drugs, monoclonal antibody therapeutics etc. These products are used to either prevent or treat smallpox infections.
Market Dynamics:
Increasing research funding for development of novel smallpox therapeutics is expected to drive the...
Smart home healthcare products are being increasingly used to assist in reducing healthcare costs and improving remote monitoring of health parameters. The integration of artificial intelligence (AI) and internet of things (IoT) has enabled devices to collect vital patient data and transmit it to medical professionals or caregivers. This helps identify potential health issues in patients,...